Stay updated on Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.

Latest updates to the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now displays the current site revision as v3.5.4, replacing the previous v3.5.3. This indicates a minor UI/backend update and does not modify the study record content or its results.SummaryDifference0.1%

- Check24 days agoChange DetectedRecord history now displays the study as Completed with updated Study Status, Recruitment Status, and Contacts/Locations, replacing the previous Active, not recruiting label. New version/date entries accompany the update.SummaryDifference0.6%

- Check39 days agoChange DetectedThis updates the ClinicalTrials.gov interface version label from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a UI/release revision rather than a change to the trial record itself.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision (v3.5.0) was added and an existing revision (v3.4.3) was deleted from the history.SummaryDifference0.1%

- Check89 days agoChange DetectedA new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.